(95% CI, 7.5-12.9), 7.4% (95% CI, 5.9-9.4), 5.3% (95% CI, 4.1-6.9), 2.9% (95% CI, 2.1-3.9), 3.1% (95% CI, 2.0-4.8), 2.1% (95% CI, 1.5-3.1), 2.0% (95% CI, 1.0-3.6), and 0.5% (95% CI, 0.3-1.0) in 1999-2000, 2001-2002, 2003-2004, 2005-2006, 2007-2008, 2009-2010, 2011-2012, and 2013-2014 , respectively. The decreasing trend was significant (P <.05). In children aged 1 to 5 years in the National Health Nutrition and Examination Survey 2011-2014, the estimated 97.5 percentile of blood lead level was 3.48 mg/dL.
CONCLUSIONS: Blood lead levels have been decreasing in the US population. The reference level also should decrease. It is still important to monitor blood lead levels in the population, especially among pregnant women and children aged 1 to 5 years. Lead is ubiquitous in the environment but has no known biological role in humans. 1 It can form complexes with amino acids, proteins, and thiol-containing compounds, resulting in inhibition of enzymes and induction of oxidative stress. 2 In adults, lead is well known for causing toxicity to the bone marrow, liver, kidney, and central nervous system. Recent studies also showed that high blood lead levels are associated with an increase in systolic blood pressure and mortality. [3] [4] [5] Pregnant women with high blood lead levels are at risk of spontaneous abortion. 6, 7 However, children are at the highest risk of lead poisoning. High blood lead levels are associated with reduced intelligence, attention deficit hyperactivity disorder, hearing impairment, and delayed puberty in girls. [7] [8] [9] Chelation therapy can be considered in children with a blood lead level of 45 mg/dL or greater, 10 but there is no evidence to show that chelation therapy is associated with any improvement in intelligence. 11 Because lead exposure can result in irreversible harm in children, 11, 12 reducing blood lead levels in the population is desirable. This is best achieved by reducing lead in the environment.
The current upper reference level for blood lead is 5 mg/dL in the United States. This reference level was set in 2012 using the 97.5th percentile of blood lead levels in children aged 1 to 5 years in the National Health Nutrition and Examination Survey (NHANES) 2007-2010. 13 Previous studies have shown a decrease in blood lead levels in the US population over the years. [14] [15] [16] However, as the events in Flint, Michigan, have shown, there is no room for complacency. The crisis was due to a decision made by the local government to use Flint River as the source for tap water. The proportion of children aged 1 to 5 years with a blood lead level !5 mg/dL was 2.5%. 17 Therefore, we analyzed the trend in blood lead levels in the US population using the latest data from NHANES and estimated the proportion of children with an elevated lead level, defined as 5 mg/dL or greater.
MATERIALS AND METHODS
NHANES is a continuous national survey conducted by the US Centers for Disease Control and Prevention. Detailed methodology and protocols are described on its webpage. 18 Each participant represents approximately 50,000 Americans. The study was approved by the Research Ethics Review Board at the National Center for Health Statistics. All participants gave informed consent.
We used the NHANES dataset from 1999 to 2014. For inclusion in the analysis, a blood lead level had to be available. Included participants were stratified according to the year of survey, age, gender, ethnicity, poverty income ratio, and pregnancy status.
Venous blood samples were obtained to measure blood lead levels according to a standard protocol. Samples were frozen at À20 C and shipped in dry ice until analysis. After thawing, samples were diluted and analyzed with an Inductively Coupled Plasma Dynamic Reaction Cell Mass Spectrometer (ELAN DRC II, PerkinElmer, Norwalk). 19 The limits of detection were 0. Blood lead levels below the lower limit of detection were assigned a value equal to the lower detection limit divided by O2.
Statistical Analysis
Results were analyzed using SPSS complex sample module version 22.0 (IBM Corp, Armonk, NY). Sample weights were applied to account for unequal probabilities of selection, nonresponse bias, and oversampling. Natural logarithmtransformed blood lead levels were used to normalize the distribution of blood lead levels.
The proportions of children aged 1 to 5 years and pregnant women with elevated blood lead level, defined as 5 mg/dL or greater, were estimated. Blood lead levels were expressed as geometric means and 95% confidence intervals (CIs). Categoric variables were expressed as percentages. Analysis of variance or t test was used to compare blood lead levels in different groups in the same sampling period. Multiple regression was used to analyze trends in blood lead level across sampling periods. A 2-tailed P value of <.05 was considered statistically significant. The 97.5th percentile of the blood lead level in children aged 1 to 5 years in NHANES 2011-2014 also was estimated. Table 1 ). The decreasing trend of blood lead levels across the years was significant (P <.001).
RESULTS
We further analyzed subgroups stratified by age, gender, and ethnicity. Mean blood lead levels stratified by age are summarized in Figure 1 . There was a significant reduction in blood lead levels in all age groups (P <.001) (Figure 1 ). Blood lead levels stratified by age and gender are summarized in Supplementary Table 1, available online. There was a significant decrease (P <.001) in all age groups and genders. Blood lead levels stratified by ethnicity are summarized in Supplementary Table 2 , available online).
CLINICAL SIGNIFICANCE
The mean blood lead levels in pregnant women and in children aged 1 to 5 years are summarized in Supplementary  Table 3 , available online. The proportion of pregnant women with elevated blood lead level also decreased with marginal significance (P ¼ .053) ( Table 2 ). The proportion of children aged 1 to 5 years with an elevated lead level decreased from 9.9% (95% CI, 7.5-12.9) in 1999-2000 to 0.5% (95% CI, 0.3-1.0) in 2013-2014 (P <.001) (Figure 2) . The estimated 97.5th percentile of the blood lead level in children aged 1 to 5 years in NHANES 2011-2014 was 3.48 mg/dL.
DISCUSSION
Data from NHANES were used because it is a large-scale survey representative of the US noninstitutionalized population. 20 Moreover, participants of all ages, including infants, children, and pregnant women, were included. The protocol in NHANES is standardized and therefore facilitates comparison across the years. Lead was measured in a centralized laboratory according to a strict protocol.
Previous studies have reported a decreasing trend in blood lead levels in the US populations among different age groups and ethnicities. 13, 16, 21, 22 Our analysis confirmed this decreasing trend and showed that there were further decreases in recent years. This is encouraging and demonstrates the effectiveness of long-term measures to reduce lead exposure in the United States. Compared with the results of the Canadian Health and Measures Survey and the Korean National Health and Nutrition Examination Survey in the corresponding age groups, the mean blood lead levels in NHANES were lower. 23, 24 We found that less than 1% of children had a blood lead level !5 mg/dL in 2013-2014. There were no pregnant women in the sample population with an elevated blood lead level. It may be timely to revise the blood lead reference level to reflect the decrease in blood lead levels in the United States. Our analysis suggested that the upper reference level for blood lead should be reduced to 3.5 mg/dL.
In contrast to the declining blood lead levels across the United States, the switch to Flint River as the source of water resulted in increased release of lead in pipes and elevated blood lead level in the residents of Flint, Michigan. 25, 26 In children, this is of particular concern because lead is detrimental to neurocognitive development. The lesson that should be learned is that public health measures to monitor and reduce population exposure to lead in the environment should not be relaxed. Continued vigilance is essential to good public health.
Study Limitations
Our analysis was not without limitations. The study population was not a cohort, and the participants, who were chosen randomly, differed in successive surveys. Blood samples were obtained only once in each participant, so fluctuations of blood levels with time among individuals could not be captured. Because lead is mainly deposited in bones, the cumulative exposure of lead could not be measured simply by blood test. This is especially relevant to immigrants, who may have been exposed to lead before living in the United States. Immigrants and refugees within 6 months of arrival in the United States are more likely to have elevated blood lead levels. [27] [28] [29] The Centers for Disease Control and Prevention has introduced a program to monitor population groups. Previous studies showed elevated blood lead levels in Mexican Americans 25 and the poor, 20 but this was not evident in the latest NHANES data. 
CONCLUSIONS
There has been a continuous decreasing trend in blood lead levels in the US population. Because blood lead level in young children is a very important health issue, monitoring of blood lead levels at the population level should be continued.
